Search
Menu
Excelitas PCO GmbH - PCO.Edge 11-24 BIO LB

Bio-Rad Buys Ciphergen's Proteomics Instrument Biz

Facebook X LinkedIn Email
FREMONT and HERCULES, Calif., Aug. 15, 2006 -- Molecular diagnostic products maker Ciphergen Biosystems Inc. and Bio-Rad Laboratories Inc. announced yesterday that Bio-Rad will acquire Ciphergen's proteomics instrument business for $20 million in cash. In addition, Bio-Rad will make a $3 million equity investment in Ciphergen. Ciphergen's instrument business includes its surface-enhanced laser desorption/ionization (SELDI) technology, ProteinChip arrays and accompanying software. Under the terms of the agreement, Bio-Rad will manufacture, sell and market the SELDI technology to the life sciences marketplace for proteomics...Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: August 2006
    Glossary
    biomarker
    A biomarker, short for biological marker, refers to a measurable and quantifiable indicator of a biological condition, process, or response. Biomarkers can be substances or characteristics that are objectively measured and evaluated as an indicator of normal biological processes, pathogenic processes, or pharmacological responses to therapeutic interventions. These markers are often used in medical and scientific contexts to assess health status, diagnose diseases, monitor treatment outcomes,...
    acquireBio-Rad LaboratoriesbiomarkerBiophotonicsCiphergen Biosystemsclinical diagnosticslife scienceNews & FeaturesproteomicsQest DiagnosticsSELDItransactionLasers

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.